For Research Use Only. Not for Human Consumption.
Recorded market$58.29Recorded exact-size market estimate: 58.29 USD for one 10 mg container (5.829400 USD/mg). Arithmetic mean of 10 recorded supplier prices for this same vial or container size and formulation, with no extrapolation from other sizes. Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. Non-USD prices use ECB exchange rates dated October 9, 2026. Shipping excluded; supplier tax treatment is retained as recorded. This is a dated price comparison, not a former Peptide Serum price or an assurance of potency, purity, dosing or medical equivalence.Public price$66.56Member price$59.90No member savings vs. this market reference
GnRH-axis signaling peptide for endocrine research.
Exact-size price research
Supplier observation dates: Oct 10, 2026 UTC to Oct 11, 2026 UTC. This reference uses recorded prices for the same 10 mg vial or container and formulation. No prices are extrapolated from smaller or larger vials. Peptide Serum member unit prices refresh from the current catalog. Paid PRO membership is required for member pricing.
$5.99/mg
Peptide Serum reference: Member unit price (USD), available with verified paid PRO membership; excludes shipping and applicable taxes. Read from catalog: Oct 23, 2026 05:16 UTC. 1 x 10 mg = 10 mg total.
Source: PeptideSerum-exact-size-market-comparison.xlsx. One selected single-container price per supplier domain, for the same labeled vial size and formulation. Blends match recorded component amounts. The arithmetic mean uses the first ten selected supplier prices in recorded Google discovery order, or the true smaller sample when ten could not be found. No size scaling, mg-to-IU conversion, pack discount or minimum price range is substituted.
The green percentage, when shown, compares the member price for every visitor: (recorded exact-size market average minus Peptide Serum member price) divided by the recorded market average. Unrounded values are used and the percentage is rounded down to one decimal. It is omitted when the member price is equal to or above the reference or the refreshed snapshot cannot be confirmed. Member pricing requires verified paid PRO membership.
These are dated price observations, not live available supplier offers. Shipping is excluded. Supplier tax treatment is retained as recorded and can differ. Memberships, clinical qualifications, ancillary supplies and availability can affect comparability; source notes retain these limitations. Some observations were sold out. Seller domains may be correlated through one manufacturer. This is not a revenue-ranked or complete-market survey.
Non-USD native prices are converted using ECB reference rates dated October 9, 2026. Recorded exchange-rate source. Original prices and currencies are shown below. Currency conversion does not make tax treatment or purchasing conditions identical.
| Source / recorded date | Exact vial / native price | USD per mg | Recorded coverage / conditions |
|---|---|---|---|
| Eppix Labs Oct 10, 2026 UTC | One 10 mg container; 39.99 USD | $4.00/mg | powder; publicly listed Selected labeled 10mg single vial; FAQ says 12mg while batch reports 13.21mg actual. Comparison uses nominal 10mg label, conflicting FAQ noted. Price observation; no COA authentication is implied by inclusion. |
| Ascension Peptides Oct 10, 2026 UTC | One 10 mg container; 60.00 USD | $6.00/mg | powder; publicly listed Public10mg singlelyophilized vial $60. Currency newlyverified in supplierTerms: allpricesquotedUnitedStatesdollars. Price observation; no COA authentication is implied by inclusion. |
| Core Peptides Oct 10, 2026 UTC | One 10 mg container; 63.00 USD | $6.30/mg | powder; publicly listed Single unit price; 10mg lyophilized decapeptide specified. Price observation; no COA authentication is implied by inclusion. |
| Jonezie Labs Oct 10, 2026 UTC | One 10 mg container; 47.99 USD | $4.80/mg | powder; publicly listed Published 10mg single-vial variant row, USD offer currency on page; default 5mg variant not used. Price observation; no COA authentication is implied by inclusion. |
| Pure Bio Labs Oct 11, 2026 UTC | One 10 mg container; 109.99 USD | $11.00/mg | lyophilized powder; In stock Price observation; no COA authentication is implied by inclusion. |
| Peptide Society Oct 11, 2026 UTC | One 10 mg container; 49.99 USD | $5.00/mg | lyophilized powder; In stock Price observation; no COA authentication is implied by inclusion. |
| SwissChems Oct 11, 2026 UTC | One 10 mg container; 59.99 USD | $6.00/mg | powder; OutOfStock PublicProductVariant maps Kisspeptin10mg1vial to59.99USD/OutOfStock, matches visible59.99–599.90 range; tenvialkit599.90excluded. PublicsupplierFAQ states peptides freeze-driedpowder (evidence/swisschems.is-form-faq.json). Catalogopen withoutentrygate. Price observation; no COA authentication is implied by inclusion. |
| Island Peptides Oct 11, 2026 UTC | One 10 mg container; 54.00 USD | $5.40/mg | lyophilized powder; In stock Price observation; no COA authentication is implied by inclusion. |
| Biotech Compounds Oct 11, 2026 UTC | One 10 mg container; 52.99 USD | $5.30/mg | lyophilized powder; In stock Price observation; no COA authentication is implied by inclusion. |
| Alkaline Peptides Oct 11, 2026 UTC | One 10 mg container; 45.00 USD | $4.50/mg | lyophilized powder; In stock; final stock/manual payment confirmation Price observation; no COA authentication is implied by inclusion. |
Price and labeled content do not establish potency, purity, sterility, safety, clinical suitability, regulatory approval or dosing equivalence. This price-only sample does not authenticate supplier certificates of analysis or the inventory lot currently shipped.
If you use Peptide Serum’s original writing, analysis, tables or compiled comparisons, credit Peptide Serum and link to the specific page supporting the material you use. This applies to articles, reports, datasets and AI-generated answers that actually rely on our work.
Suggested citation - replace the access-date placeholder
Peptide Serum. “Kisspeptin – 10 mg | Catalog & Research – Peptide Serum.” https://peptideserum.com/product/kisspeptin-10-mg/ Accessed [your access date].
Source page: https://peptideserum.com/product/kisspeptin-10-mg/
A signaling peptide central to GnRH-axis regulation, used in reproductive-endocrinology research models.
Supplied sealed for laboratory handling. Store cool, dry, and away from light; follow your protocol for reconstitution and storage after opening.
For in-vitro laboratory research only. Not for human or veterinary use.
Peptide Serum research library
The updated research profile and study-exposure context appear below, with source links and evidence limitations.
Kisspeptin refers to related peptides involved in reproductive hormone signaling. Human studies of kisspeptin-54 in assisted reproduction provide direct evidence for a specific clinical research question. They should not be generalized to every kisspeptin form or to an unspecified “hormone reset” product.
The numbers in kisspeptin-54 and kisspeptin-10 identify different peptide forms. They must remain explicit in a study summary and product identity.
A reproductive-hormone signal, maturation of eggs, pregnancy and live birth are different outcomes. Evidence for an earlier step does not automatically prove the final clinical result.
An initial study tested kisspeptin-54 as an egg-maturation trigger during a complete IVF pathway. A later randomized study in women at high risk of ovarian hyperstimulation compared a second trigger exposure with placebo after an initial exposure. These are specific, monitored treatment settings, not standalone fertility supplementation.
| Study and design | Finding | What it does not establish |
|---|---|---|
| Kisspeptin-54 as an IVF trigger
Clinical study in 53 women undergoing assisted reproduction Reading scope: PubMed abstract |
The study demonstrated egg maturation and reported subsequent fertilization and pregnancies. | It did not compare an unspecified kisspeptin product with no fertility care or establish every reproductive use. |
| A second kisspeptin-54 exposure in IVF
Randomized phase 2 study in 62 women at high risk of ovarian hyperstimulation Reading scope: PubMed abstract |
The second-exposure group more often reached the study’s target egg-yield endpoint. | A selected group and specific protocol limit generalization; this is not direct evidence for kisspeptin-10. |
For the differences between a mechanism, a biomarker and a clinical outcome, see the evidence-reading guide.
The entire care pathway matters. Participants received other fertility medicines, monitoring and procedures. Attributing every pregnancy to a single trigger ignores that context.
A promising result in a selected group also does not establish that the method is best for everyone. Comparative effectiveness depends on the comparator, eligibility criteria and outcome chosen.
Evidence about reproductive signaling should not be repackaged as proof of a reliable libido, testosterone or mood benefit. Each proposed use needs its own directly relevant study and formulation.
When reading a result, look for the denominator: eggs, cycles and patients are not interchangeable. A percentage about egg yield cannot be presented as a person’s chance of pregnancy.
The controlled fertility studies do not establish safety for unsupervised use or another isoform. The clinical setting included selection and monitoring that a product label or concentration calculator does not reproduce.
The clinical research exposure is part of a specific IVF protocol. It is not a general fertility, sexual-health or hormone-optimization schedule.
A mass conversion between isoforms cannot establish equivalent biological exposure. The sequence, formulation and timing pattern remain necessary to interpret a study.
Match any reported amount or concentration to the exact material, route, population and duration in the original experiment. Read the guide to mass, volume and concentration for the meaning of common units. A calculation cannot establish an appropriate treatment or validate an untested formulation.
Confirm the precise isoform and full sequence, along with quantity and formulation. A report saying only “kisspeptin” leaves the most important identity question unanswered.
Clinical-trial citations cannot establish that a separate product is the same study preparation or an authorized medicine.
Keep the clinical evidence and the supplier evidence separate. Use the report-verification steps to check the issuer and the batch questions to connect a tested sample with the product offered. Compare prices using the delivered-cost method rather than an isolated discount or purity percentage.
Peptide Serum operates a store as well as this research library. The supplier directory contains imported seller information; a listing is not laboratory certification. Read how this library is prepared and evaluate the documentation for the exact lot offered. A seller rating does not establish clinical safety or effectiveness.
Not automatically. They are different forms with their own exposure questions. The actual peptide in the study must remain identified.
It is an important earlier endpoint, but live birth requires separate measurement and an appropriate comparison.
This companion to the Kisspeptin research profile explains how to interpret experimental quantities. It provides no personal-use regimen.
The clinical research exposure is part of a specific IVF protocol. It is not a general fertility, sexual-health or hormone-optimization schedule.
A mass conversion between isoforms cannot establish equivalent biological exposure. The sequence, formulation and timing pattern remain necessary to interpret a study.
Find the tested material, formulation, route, study population, comparison group and observation period in the original paper. Exposure in a cell system or animal model does not supply a human starting amount, schedule or route.
Mass describes an amount of material; concentration describes that amount per final solution volume. One milligram equals 1,000 micrograms. Neither a vial label nor arithmetic establishes identity, stability, sterility or an appropriate use.
Read the units reference and the study summaries and their limitations. Use the original methods for the precise experimental conditions; do not transfer a reported amount between different materials or study models.
The main profile links the selected primary sources, distinguishes the study designs and explains what the findings cannot show. A trial registration is a research plan, not a published result.
Reviews
There are no reviews yet.